Loading...

Stay current with insights from our analysts and industry updates.  Subscribe to one of our HealthCheck24 newsletters to receive regular growth markets insights by email. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.

Malaysian Health Ministry may extend moratorium on new medical programmes

Image

29-Feb-16 Malaysia's Ministry of Health is looking to extend the five year moratorium imposed by the government in 2011 on new medical programmes in the country. There were the 46,916 registered doctors in 2014, with a doctor to population ratio of 1:633, which the government plans to bring down to 1:400 by 2020. [image: Edubeanz]

Read More

UK turns to India to fill vacancies

Image

29-Feb-16 The UK is turning to India in an attempt to fill thousands of vacancies for doctors and nurses in its state-funded National Health Service, but "unwise regulations" and a changing visa regime have been making the British medical system less attractive for Indian doctors. [image: The Times of India]

Read More

Japan amends Pharmaceutical Affairs Act to attract Indian pharma

Image

29-Feb-16 The Japanese External Trade Organization (JETRO), which has set a foreign direct investment target of USD300 bn by 2020, is now wooing Indian pharmaceutical companies to maximize its conducive research-innovation ecosystem and advanced manufacturing infrastructure. To this end Japan has amended the Pharmaceutical Affairs Act, drastically improving the approval process for medicine and medical devices. [image: JETRO]

Read More

Webinar: Indonesia healthcare market opportunities

Image

 Webinars

Watch the recording of our webinar on the Pharmaceutical & HealthCare Marketing BrightTALK channel: Global Growth Markets CEO Pete Read talks about Indonesia’s healthcare market fundamentals, the challenges faced, improvements in progress, how technology can help and opportunities for investment.

Read More

China to speed up approvals for some drugs

Image

27-Feb-16 The CFDA has said it would prioritize the approval of drugs with clear clinical value, including those that use advanced technology or innovative methods. It added that certain categories of drugs would get priority, including those for children and the elderly, rare diseases, AIDS, malignant tumors and viral hepatitis. [image: Aly Song / Reuters]

Read More
Share

 


0111 Banner square pre launch 250x250